Table 4.
Alterations in liver function tests in the patients who developed anti-TB DIH
| Variable | Patients with anti-TB DIH (N = 15) | |
|---|---|---|
| n | % | |
| ALT in all the 15 cases | ||
| ≤3 times ULN | 9 | 60.00 |
| 3–4 times ULN | 4 | 26.67 |
| >4 times ULN | 2 | 13.33 |
| AST in all the 15 cases | ||
| ≤3 times ULN | 8 | 53.33 |
| 3–4 times ULN | 6 | 40.00 |
| >4 times ULN | 1 | 6.67 |
| Raised bilirubin in 7 cases | ||
| 1.5–2 mg/dl | 2 | 28.57 |
| 2–3 mg/dl | 1 | 14.29 |
| >3 mg/dl | 4 | 57.14 |
Note: ULN, upper limit of normal; n, number; DIH, drug-induced hepatotoxicity; ALT, alanine aminotransferase; AST, aspartate aminotransferase